title: Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.
abstract: Selective rubella vaccination of schoolgirls in Italy started 14 years ago following the United Kingdom strategy that was adopted in 1970. The aims of this program were to eliminate the risk of rubella among women of childbearing age, encourage the acquisition of immunity by natural infection during early childhood and allow the vaccine-induced antibody production by the circulating virus. On the basis of this program, between 1982 to 1990, a prospective serosurvey for rubella antibody in the province of Pavia was performed. The results showed a decline in the overall seropositivity rate for rubella antibodies from 57.7% in 1982 to 41.9% in 1984 followed by a remarkable increase in 1985 (53.3%) and in 1987 (56.5%). This trend was confirmed by the number of cases reported to the local Public Health Service. The results of this study provide further evidence of the need to change the current selective immunization policy in order to obtain a significant reduction of risk of the infection in the population.
authors.affiliation: Dipartimento di Medicina Preventiva, Occupazionale e di Comunità, Università degli Studi di Pavia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Pelissero
authors.forename: C
authors.initials: C
authors.lastname: Marena
authors.forename: F
authors.initials: F
authors.lastname: Aguzzi
authors.forename: M
authors.initials: M
authors.lastname: Bevilacqua
authors.forename: F
authors.initials: F
authors.lastname: Rebasti
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006291:Health Policy; D006306:Health Surveys; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D007558:Italy / Q000453:epidemiology; D008297:Male; D009017:Morbidity; D011159:Population Surveillance; D011446:Prospective Studies; D012307:Risk Factors; D012409:Rubella / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control*; D012412:Rubella virus / Q000276:immunology*; D016036:Seroepidemiologic Studies; D014611:Vaccination; D014932:Women's Health Services / Q000458:organization & administration*
chemical_list: D000914:Antibodies, Viral